U2AF1 and myelodysplastic syndrome: To the best of our knowledge apart from the aforementioned studies, limited information is available on the molecular profile, myeloid co-mutation pattern and survival outcomes with unique U2AF1 MT in patients with clonal cytopenia of undetermined significance (CCUS), MDS, MDS/AML and AML.